Pink SheetScripMedtech InsightHBW InsightGenerics BulletinIn Vivo

Generics Bulletin

Medtech Insight

‘Wait-and-See Time’: Panel Predicts Limited Congressional Action On Devices This Year

May 24 2023

• By Elizabeth Orr

US Capitol, Washington DC (f11photo/Shutterstock.com)

Related Content

FDA Encourages Voluntary Device Shortage Reporting After PHE End

May 16 2023

‘We Need More Time‘: Medtech Groups Testify Before EPA On ETO Emissions Regulation

May 11 2023

Year-End Spending Bill Sets FDA 2023 Budget At $6.6B

Dec 21 2022

Diagnostics Reform Reintroduced in House

Mar 31 2023

What Should Be Included In PAHPA's Reauthorization?

Apr 04 2023

Additional Topics

United States Legislation Policy Lobbying FDA Medical Device

More from Legislation

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window